| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.826 | 0.003 | 0.832 | DNA synthesis inhibitor | 0.832 0.003 DBMET01435 | DBMET01435 | |
| 0.687 | 0.005 | 0.687 | DNA damaging | 0.53 0.012 DBMET01435 | ||
| 0.654 | 0.001 | 0.703 | UDP-glucose 4-epimerase inhibitor | 0.703 0 DBMET01435 | DBMET01435 | |
| 0.633 | 0.004 | 0.722 | RNA-directed DNA polymerase inhibitor | 0.722 0.002 DBMET01435 | DBMET01435 | |
| 0.602 | 0.004 | 0.668 | DNA methylase inhibitor | 0.668 0.003 DBMET01435 | DBMET01435 | |
| 0.581 | 0.004 | 0.602 | Adenylate cyclase inhibitor | 0.602 0.004 DBMET01435 | DBMET01435 | |
| 0.584 | 0.018 | 0.688 | Vasodilator, peripheral | 0.688 0.007 DBMET01435 | DBMET01435 | |
| 0.582 | 0.022 | 0.582 | Antibacterial | 0.575 0.024 DBMET01435 | ||
| 0.562 | 0.004 | 0.562 | Alkylator | 0.403 0.007 DBMET01435 | ||
| 0.524 | 0.002 | 0.728 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.728 0.001 DBMET01435 | DBMET01435 | |
| 0.569 | 0.056 | 0.569 | Apoptosis agonist | 0.395 0.116 DBMET01435 | ||
| 0.515 | 0.005 | 0.775 | Cytidine deaminase inhibitor | 0.775 0.002 DBMET01435 | DBMET01435 | |
| 0.504 | 0.002 | 0.538 | Antimetabolite | 0.538 0.002 DBMET01435 | DBMET01435 | |
| 0.521 | 0.026 | 0.521 | Immunostimulant | 0.519 0.027 DBMET01435 | ||
| 0.529 | 0.05 | 0.815 | Caspase 9 stimulant | 0.815 0.009 DBMET01435 | DBMET01435 | |
| 0.453 | 0.005 | 0.596 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.596 0.003 DBMET01435 | DBMET01435 | |
| 0.479 | 0.039 | 0.479 | Immunosuppressant | 0.405 0.06 DBMET01435 | ||
| 0.432 | 0.035 | 0.432 | Caspase 3 stimulant | 0.255 0.108 DBMET01435 | ||
| 0.352 | 0.003 | 0.698 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.698 0 DBMET01435 | DBMET01435 | |
| 0.35 | 0.005 | 0.403 | DNA directed RNA polymerase inhibitor | 0.403 0.005 DBMET01435 | DBMET01435 | |
| 0.355 | 0.011 | 0.429 | Peptidyltransferase inhibitor | 0.429 0.005 DBMET01435 | DBMET01435 | |
| 0.392 | 0.051 | 0.536 | Cholesterol antagonist | 0.536 0.027 DBMET01435 | DBMET01435 | |
| 0.344 | 0.008 | 0.486 | DNA polymerase I inhibitor | 0.486 0.004 DBMET01435 | DBMET01435 | |
| 0.336 | 0.003 | 0.66 | Argininosuccinate synthase inhibitor | 0.66 0.001 DBMET01435 | DBMET01435 | |
| 0.357 | 0.031 | 0.357 | Vasodilator | 0.348 0.034 DBMET01435 | ||
| 0.337 | 0.016 | 0.624 | DNA methyltransferase I inhibitor | 0.624 0.003 DBMET01435 | DBMET01435 | |
| 0.321 | 0.004 | 0.489 | DNA repair enzyme inhibitor | 0.489 0.003 DBMET01435 | DBMET01435 | |
| 0.341 | 0.028 | 0.657 | Cyclic AMP phosphodiesterase inhibitor | 0.657 0.004 DBMET01435 | DBMET01435 | |
| 0.351 | 0.059 | 0.419 | Immunomodulator | 0.419 0.039 DBMET01435 | DBMET01435 | |
| 0.318 | 0.028 | 0.318 | Platelet adhesion inhibitor | 0.291 0.037 DBMET01435 | ||
| 0.278 | 0.006 | 0.692 | Phosphofructokinase-1 inhibitor | 0.692 0.001 DBMET01435 | DBMET01435 | |
| 0.253 | 0.006 | 0.409 | Mucolytic | 0.409 0.003 DBMET01435 | DBMET01435 | |
| 0.25 | 0.013 | 0.445 | Expectorant | 0.445 0.004 DBMET01435 | DBMET01435 | |
| 0.31 | 0.08 | 0.488 | Vasodilator, coronary | 0.488 0.017 DBMET01435 | DBMET01435 | |
| 0.228 | 0.003 | 0.759 | Fumarate hydratase inhibitor | 0.759 0.001 DBMET01435 | DBMET01435 | |
| 0.307 | 0.084 | 0.369 | Antithrombotic | 0.369 0.058 DBMET01435 | DBMET01435 | |
| 0.225 | 0.009 | 0.343 | Aminoacyl-tRNA synthetase inhibitor | 0.343 0.005 DBMET01435 | DBMET01435 | |
| 0.209 | 0.009 | 0.263 | HIV-1 reverse transcriptase inhibitor | 0.263 0.006 DBMET01435 | DBMET01435 | |
| 0.199 | 0.003 | 0.703 | Thymidine kinase inhibitor | 0.703 0.001 DBMET01435 | DBMET01435 | |
| 0.195 | 0.005 | 0.195 | Phosphodiesterase 6D inhibitor | 0.149 0.01 DBMET01435 | ||
| 0.214 | 0.025 | 0.242 | Cell wall synthesis inhibitor | 0.242 0.018 DBMET01435 | DBMET01435 | |
| 0.207 | 0.025 | 0.309 | Topoisomerase I inhibitor | 0.309 0.01 DBMET01435 | DBMET01435 | |
| 0.187 | 0.006 | 0.423 | Biliverdin reductase inhibitor | 0.423 0.002 DBMET01435 | DBMET01435 | |
| 0.228 | 0.051 | 0.271 | Hepatoprotectant | 0.271 0.038 DBMET01435 | DBMET01435 | |
| 0.182 | 0.005 | 0.509 | Phosphorylase inhibitor | 0.509 0.002 DBMET01435 | DBMET01435 | |
| 0.248 | 0.08 | 0.381 | Interleukin agonist | 0.381 0.022 DBMET01435 | DBMET01435 | |
| 0.185 | 0.017 | 0.359 | Adenylate kinase inhibitor | 0.359 0.004 DBMET01435 | DBMET01435 | |
| 0.275 | 0.11 | 0.275 | Transcription factor NF kappa B inhibitor | 0.272 0.112 DBMET01435 | ||
| 0.169 | 0.008 | 0.508 | Ornithine carbamoyltransferase inhibitor | 0.508 0.002 DBMET01435 | DBMET01435 | |
| 0.164 | 0.01 | 0.499 | Carbamoyl phosphate synthetase inhibitor | 0.499 0.002 DBMET01435 | DBMET01435 | |
| 0.166 | 0.014 | 0.611 | NADH dehydrogenase inhibitor | 0.611 0.002 DBMET01435 | DBMET01435 | |
| 0.193 | 0.044 | 0.218 | Protein kinase stimulant | 0.218 0.036 DBMET01435 | DBMET01435 | |
| 0.146 | 0.001 | 0.591 | Uridine phosphorylase inhibitor | 0.591 0 DBMET01435 | DBMET01435 | |
| 0.15 | 0.009 | 0.15 | Carbonic anhydrase VB inhibitor | 0.112 0.014 DBMET01435 | ||
| 0.156 | 0.015 | 0.156 | Thioredoxin inhibitor | |||
| 0.15 | 0.011 | 0.153 | Carbonic anhydrase VA inhibitor | 0.153 0.01 DBMET01435 | DBMET01435 | |
| 0.152 | 0.014 | 0.161 | Carbonic anhydrase V inhibitor | 0.161 0.012 DBMET01435 | DBMET01435 | |
| 0.222 | 0.086 | 0.222 | Platelet antagonist | 0.22 0.088 DBMET01435 | ||
| 0.141 | 0.005 | 0.233 | Purinergic P2Y antagonist | 0.233 0.004 DBMET01435 | DBMET01435 | |
| 0.145 | 0.013 | 0.228 | Ribonucleotide reductase inhibitor | 0.228 0.006 DBMET01435 | DBMET01435 | |
| 0.182 | 0.053 | 0.22 | Interleukin 6 antagonist | 0.22 0.031 DBMET01435 | DBMET01435 | |
| 0.142 | 0.013 | 0.142 | Carbonic anhydrase XII inhibitor | |||
| 0.229 | 0.101 | 0.229 | Spasmolytic | 0.212 0.11 DBMET01435 | ||
| 0.189 | 0.072 | 0.189 | Nitric oxide antagonist | 0.162 0.086 DBMET01435 | ||
| 0.247 | 0.131 | 0.267 | Apoptosis antagonist | 0.267 0.111 DBMET01435 | DBMET01435 | |
| 0.112 | 0.004 | 0.151 | Adenine nucleotide translocase inhibitor | 0.151 0.003 DBMET01435 | DBMET01435 | |
| 0.166 | 0.061 | 0.439 | Hexokinase inhibitor | 0.439 0.004 DBMET01435 | DBMET01435 | |
| 0.123 | 0.022 | 0.405 | Glutamate dehydrogenase inhibitor | 0.405 0.004 DBMET01435 | DBMET01435 | |
| 0.117 | 0.017 | 0.117 | Carbonic anhydrase IX inhibitor | |||
| 0.121 | 0.024 | 0.173 | Transcription factor NF kappa B stimulant | 0.173 0.012 DBMET01435 | DBMET01435 | |
| 0.127 | 0.034 | 0.149 | Anabolic | 0.149 0.019 DBMET01435 | DBMET01435 | |
| 0.095 | 0.004 | 0.142 | Purinergic P2Y2 antagonist | 0.142 0.003 DBMET01435 | DBMET01435 | |
| 0.091 | 0.003 | 0.682 | Thymidine phosphorylase inhibitor | 0.682 0.001 DBMET01435 | DBMET01435 | |
| 0.135 | 0.05 | 0.135 | DNA intercalator | 0.129 0.052 DBMET01435 | ||
| 0.199 | 0.114 | 0.211 | Antioxidant | 0.211 0.107 DBMET01435 | DBMET01435 | |
| 0.107 | 0.023 | 0.309 | Adenosine A3 receptor antagonist | 0.309 0.005 DBMET01435 | DBMET01435 | |
| 0.096 | 0.012 | 0.096 | Carbonic anhydrase XIV inhibitor | 0.044 0.041 DBMET01435 | ||
| 0.086 | 0.006 | 0.165 | Thymidylate synthase inhibitor | 0.165 0.003 DBMET01435 | DBMET01435 | |
| 0.106 | 0.032 | 0.106 | ATPase (Vacuolar H+) inhibitor | |||
| 0.118 | 0.045 | 0.118 | Toll-Like receptor 4 antagonist | |||
| 0.145 | 0.072 | 0.201 | Adenylate cyclase stimulant | 0.201 0.013 DBMET01435 | DBMET01435 | |
| 0.093 | 0.021 | 0.151 | Ribonucleoside-diphosphate reductase inhibitor | 0.151 0.011 DBMET01435 | DBMET01435 | |
| 0.117 | 0.052 | 0.312 | AMP-activated protein kinase stimulant | 0.312 0.005 DBMET01435 | DBMET01435 | |
| 0.071 | 0.013 | 0.134 | Adenosine deaminase inhibitor | 0.134 0.003 DBMET01435 | DBMET01435 | |
| 0.185 | 0.128 | 0.235 | Hypoglycemic | 0.235 0.086 DBMET01435 | DBMET01435 | |
| 0.058 | 0.003 | 0.492 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.492 0.001 DBMET01435 | DBMET01435 | |
| 0.076 | 0.021 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 DBMET01435 | DBMET01435 | |
| 0.051 | 0.003 | 0.072 | Purinergic P2 agonist | 0.072 0.002 DBMET01435 | DBMET01435 | |
| 0.051 | 0.003 | 0.072 | Purinergic receptor agonist | 0.072 0.002 DBMET01435 | DBMET01435 | |
| 0.119 | 0.072 | 0.315 | Aldehyde dehydrogenase inhibitor | 0.315 0.01 DBMET01435 | DBMET01435 | |
| 0.055 | 0.008 | 0.125 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.125 0.002 DBMET01435 | DBMET01435 | |
| 0.044 | 0.003 | 0.063 | Purinergic P2Y agonist | 0.063 0.002 DBMET01435 | DBMET01435 | |
| 0.044 | 0.007 | 0.109 | Adenosine A1 receptor agonist | 0.109 0.004 DBMET01435 | DBMET01435 | |
| 0.079 | 0.042 | 0.079 | Phosphodiesterase VI inhibitor | |||
| 0.038 | 0.003 | 0.06 | Isoleucine-tRNA ligase inhibitor | 0.06 0.002 DBMET01435 | DBMET01435 | |
| 0.087 | 0.053 | 0.087 | Antineoplastic antibiotic | 0.08 0.058 DBMET01435 | ||
| 0.144 | 0.115 | 0.144 | Lipocortins synthesis antagonist | |||
| 0.038 | 0.009 | 0.049 | Purinergic P2Y12 antagonist | 0.049 0.007 DBMET01435 | DBMET01435 | |
| 0.06 | 0.031 | 0.06 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.106 | 0.078 | 0.106 | Photosensitizer | |||
| 0.086 | 0.059 | 0.086 | Antineoplastic alkaloid | |||
| 0.031 | 0.004 | 0.131 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.131 0.001 DBMET01435 | DBMET01435 | |
| 0.037 | 0.011 | 0.037 | Elastase 3A inhibitor | |||
| 0.037 | 0.011 | 0.037 | Elastase 3B inhibitor | |||
| 0.037 | 0.011 | 0.037 | Elastase 2B inhibitor | |||
| 0.06 | 0.033 | 0.163 | Acyl-CoA dehydrogenase inhibitor | 0.163 0.008 DBMET01435 | DBMET01435 | |
| 0.071 | 0.045 | 0.071 | Elastase 1 inhibitor | |||
| 0.04 | 0.014 | 0.227 | HCV NS5B polymerase inhibitor | 0.227 0.003 DBMET01435 | DBMET01435 | |
| 0.111 | 0.087 | 0.448 | Alpha-N-acetylglucosaminidase inhibitor | 0.448 0.007 DBMET01435 | DBMET01435 | |
| 0.146 | 0.123 | 0.146 | P-glycoprotein inhibitor | |||
| 0.081 | 0.059 | 0.081 | Acetylcholine M3 receptor agonist | |||
| 0.095 | 0.075 | 0.095 | Mediator release inhibitor | |||
| 0.039 | 0.019 | 0.141 | RNA-directed RNA polymerase inhibitor | 0.141 0.004 DBMET01435 | DBMET01435 | |
| 0.049 | 0.03 | 0.049 | Microtubule stabilization | |||
| 0.021 | 0.002 | 0.086 | Purinergic P2Y2 agonist | 0.086 0 DBMET01435 | DBMET01435 | |
| 0.024 | 0.005 | 0.048 | Purinergic P2Y1 agonist | 0.048 0.002 DBMET01435 | DBMET01435 | |
| 0.032 | 0.016 | 0.052 | Purinergic P2X agonist | 0.052 0.009 DBMET01435 | DBMET01435 | |
| 0.151 | 0.136 | 0.151 | Hypolipemic | |||
| 0.057 | 0.042 | 0.319 | Adenosine A1 receptor antagonist | 0.319 0.006 DBMET01435 | DBMET01435 | |
| 0.061 | 0.047 | 0.061 | Nitric oxide donor | |||
| 0.021 | 0.008 | 0.044 | Adenosine A3 receptor agonist | 0.044 0.004 DBMET01435 | DBMET01435 | |
| 0.036 | 0.023 | 0.312 | Phosphoglycerate kinase inhibitor | 0.312 0.002 DBMET01435 | DBMET01435 | |
| 0.13 | 0.119 | 0.13 | Ca2+-transporting ATPase inhibitor | |||
| 0.184 | 0.173 | 0.216 | Hypoxia-inducible factor 1 alpha inhibitor | 0.216 0.133 DBMET01435 | DBMET01435 | |
| 0.07 | 0.059 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.041 DBMET01435 | DBMET01435 | |
| 0.024 | 0.014 | 0.073 | Purinergic P2T antagonist | 0.073 0.007 DBMET01435 | DBMET01435 | |
| 0.035 | 0.026 | 0.071 | Inosine monophosphate dehydrogenase inhibitor | 0.071 0.008 DBMET01435 | DBMET01435 | |
| 0.084 | 0.076 | 0.139 | Uric acid excretion stimulant | 0.139 0.027 DBMET01435 | DBMET01435 | |
| 0.05 | 0.043 | 0.05 | Carbonic anhydrase I inhibitor | |||
| 0.006 | 0.002 | 0.013 | Purinergic P2Y4 agonist | 0.013 0.001 DBMET01435 | DBMET01435 | |
| 0.025 | 0.022 | 0.025 | Toll-Like receptor 4 agonist | |||
| 0.014 | 0.011 | 0.029 | Adenosine A2b receptor agonist | 0.029 0.004 DBMET01435 | DBMET01435 | |
| 0.004 | 0.002 | 0.064 | Purinergic P2Y6 agonist | 0.064 0 DBMET01435 | DBMET01435 | |
| 0.134 | 0.133 | 0.272 | Angiogenesis stimulant | 0.272 0.06 DBMET01435 | DBMET01435 | |
| 0.053 | 0.052 | 0.053 | Carbonic anhydrase inhibitor | |||
| 0.018 | 0.017 | 0.036 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.036 0.007 DBMET01435 | DBMET01435 | |
| 0.012 | 0.014 | 0.034 | Adenosine A2a receptor agonist | 0.034 0.004 DBMET01435 | DBMET01435 | |
| 0.023 | 0.027 | 0.063 | Integrin alpha2beta1 antagonist | 0.063 0.004 DBMET01435 | DBMET01435 | |
| 0.016 | 0.022 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.005 DBMET01435 | DBMET01435 | |
| 0.012 | 0.018 | 0.025 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.025 0.005 DBMET01435 | DBMET01435 | |
| 0.012 | 0.02 | 0.039 | Adenosine A2 receptor agonist | 0.039 0.004 DBMET01435 | DBMET01435 | |
| 0.03 | 0.04 | 0.055 | Antibiotic Aminoglycoside-like | 0.055 0.011 DBMET01435 | DBMET01435 | |
| 0.022 | 0.033 | 0.074 | Sodium/glucose cotransporter inhibitor | 0.074 0.004 DBMET01435 | DBMET01435 | |
| 0.127 | 0.141 | 0.183 | Heat shock protein 70 antagonist | 0.183 0.011 DBMET01435 | DBMET01435 | |
| 0.057 | 0.078 | 0.068 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.068 0.064 DBMET01435 | DBMET01435 | |
| 0.028 | 0.052 | 0.067 | Integrin alpha2 antagonist | 0.067 0.005 DBMET01435 | DBMET01435 | |
| 0.044 | 0.069 | 0.107 | Selectin antagonist | 0.107 0.025 DBMET01435 | DBMET01435 | |
| 0.011 | 0.038 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.013 DBMET01435 | DBMET01435 | |
| 0.018 | 0.044 | 0.073 | Sodium/glucose cotransporter 2 inhibitor | 0.073 0.004 DBMET01435 | DBMET01435 | |
| 0.046 | 0.074 | 0.134 | Purinergic P2X1 antagonist | 0.134 0.009 DBMET01435 | DBMET01435 | |
| 0.117 | 0.151 | 0.146 | Psychostimulant | 0.146 0.12 DBMET01435 | DBMET01435 | |
| 0.01 | 0.05 | 0.097 | Adenosine kinase inhibitor | 0.097 0.003 DBMET01435 | DBMET01435 | |
| 0.027 | 0.067 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.029 DBMET01435 | DBMET01435 | |
| 0.19 | 0.236 | 0.388 | DNA directed DNA polymerase inhibitor | 0.388 0.121 DBMET01435 | DBMET01435 | |
| 0.029 | 0.076 | 0.104 | AICAR transformylase inhibitor | 0.104 0.005 DBMET01435 | DBMET01435 | |
| 0.044 | 0.102 | 0.101 | Protein kinase C beta inhibitor | 0.101 0.013 DBMET01435 | DBMET01435 | |
| 0.023 | 0.082 | 0.073 | Guanylate cyclase inhibitor | 0.073 0.004 DBMET01435 | DBMET01435 | |
| 0.005 | 0.074 | 0.02 | Purine nucleoside phosphorylase inhibitor | 0.02 0.003 DBMET01435 | DBMET01435 | |
| 0.028 | 0.097 | 0.041 | Kainate receptor agonist | 0.041 0.03 DBMET01435 | DBMET01435 | |
| 0.03 | 0.103 | 0.056 | Purinergic P2X2 antagonist | 0.056 0.054 DBMET01435 | DBMET01435 | |
| 0.007 | 0.081 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.019 0.014 DBMET01435 | DBMET01435 | |
| 0.059 | 0.137 | 0.152 | Triose-phosphate isomerase inhibitor | 0.152 0.019 DBMET01435 | DBMET01435 | |
| 0.026 | 0.113 | 0.269 | Adenosine A2a receptor antagonist | 0.269 0.006 DBMET01435 | DBMET01435 | |
| 0.028 | 0.121 | 0.07 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 DBMET01435 | DBMET01435 | |
| 0.143 | 0.236 | 0.178 | Nitric-oxide synthase stimulant | 0.178 0.132 DBMET01435 | DBMET01435 | |
| 0.051 | 0.147 | 0.133 | Alcohol dehydrogenase inhibitor | 0.133 0.027 DBMET01435 | DBMET01435 | |
| 0.028 | 0.125 | 0.081 | Alpha-mannosidase inhibitor | 0.081 0.011 DBMET01435 | DBMET01435 | |
| 0.027 | 0.128 | 0.268 | Adenosine A2 receptor antagonist | 0.268 0.007 DBMET01435 | DBMET01435 | |
| 0.062 | 0.164 | 0.29 | Amylase inhibitor | 0.29 0.02 DBMET01435 | DBMET01435 | |
| 0.079 | 0.189 | 0.143 | Acetylcholine M1 receptor antagonist | 0.143 0.082 DBMET01435 | DBMET01435 | |
| 0.053 | 0.165 | 0.163 | Phosphodiesterase I inhibitor | 0.163 0.015 DBMET01435 | DBMET01435 | |
| 0.018 | 0.131 | 0.074 | Mannosidase inhibitor | 0.074 0.01 DBMET01435 | DBMET01435 | |
| 0.157 | 0.279 | 0.361 | Interleukin 2 agonist | 0.361 0.041 DBMET01435 | DBMET01435 | |
| 0.012 | 0.138 | 0.038 | Purinergic P2Y15 antagonist | 0.038 0.008 DBMET01435 | DBMET01435 | |
| 0.091 | 0.221 | 0.234 | Anticonvulsant | 0.234 0.063 DBMET01435 | DBMET01435 | |
| 0.081 | 0.228 | 0.243 | NOS3 expression enhancer | 0.243 0.028 DBMET01435 | DBMET01435 | |
| 0.087 | 0.253 | 0.145 | Interferon gamma antagonist | 0.145 0.084 DBMET01435 | DBMET01435 | |
| 0.097 | 0.268 | 0.171 | Phospholipase C inhibitor | 0.171 0.072 DBMET01435 | DBMET01435 | |
| 0.072 | 0.247 | 0.189 | Anesthetic general | 0.189 0.08 DBMET01435 | DBMET01435 | |
| 0.156 | 0.349 | 0.398 | Cyclophilin D inhibitor | 0.398 0.092 DBMET01435 | DBMET01435 | |
| 0.023 | 0.218 | 0.051 | Heparanase inhibitor | 0.051 0.041 DBMET01435 | DBMET01435 | |
| 0.044 | 0.241 | 0.092 | Protein kinase C gamma inhibitor | 0.092 0.091 DBMET01435 | DBMET01435 | |
| 0.011 | 0.218 | 0.073 | Adenosine A2b receptor antagonist | 0.073 0.016 DBMET01435 | DBMET01435 | |
| 0.02 | 0.227 | 0.046 | Purinergic P2X4 antagonist | 0.046 0.032 DBMET01435 | DBMET01435 | |
| 0.061 | 0.302 | 0.129 | Transcription factor STAT6 inhibitor | 0.129 0.046 DBMET01435 | DBMET01435 | |
| 0.049 | 0.304 | 0.084 | Hematopoietic | 0.084 0.063 DBMET01435 | DBMET01435 | |
| 0.065 | 0.325 | 0.125 | Insulin secretagoues | 0.125 0.104 DBMET01435 | DBMET01435 | |
| 0.136 | 0.448 | 0.197 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.197 0.175 DBMET01435 | DBMET01435 | |
| 0.017 | 0.379 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.031 DBMET01435 | DBMET01435 | |
| 0.009 | 0.4 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET01435 | DBMET01435 | |
| 0.017 | 0.446 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 DBMET01435 | DBMET01435 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |